$GTBIF

The article discusses the anticipated rescheduling of cannabis from its current classification, suggesting that it's now a question of 'when' it will occur rather than 'if'. This rescheduling is expected to pave the way for increased legitimacy and market access for cannabis companies. With potential federal legalization on the horizon, investor interest in cannabis-related stocks is likely to increase. The article highlights several companies that stand to benefit significantly from these changes. Overall, the cannabis industry may experience a surge in valuations as regulatory environments shift favorably.